Chemoinformaics analysis of 19R-Hydroxydihydrogelsemine
Molecular Weight | 340.423 | nRot | 1 |
Heavy Atom Molecular Weight | 316.231 | nRig | 26 |
Exact Molecular Weight | 340.179 | nRing | 6 |
Solubility: LogS | -3.2 | nHRing | 3 |
Solubility: LogP | 1.074 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 5 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 54.009 |
nHD | 2 | BPOL | 28.961 |
QED | 0.807 |
Synth | 6.547 |
Natural Product Likeliness | 2.21 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.009 |
Pgp-sub | 0.193 |
HIA | 0.006 |
CACO-2 | -5.162 |
MDCK | 0.0000796 |
BBB | 0.962 |
PPB | 0.24851 |
VDSS | 1.948 |
FU | 0.652331 |
CYP1A2-inh | 0.011 |
CYP1A2-sub | 0.519 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.962 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.186 |
CYP2d6-inh | 0.02 |
CYP2d6-sub | 0.83 |
CYP3a4-inh | 0.024 |
CYP3a4-sub | 0.9 |
CL | 9.882 |
T12 | 0.157 |
hERG | 0.108 |
Ames | 0.026 |
ROA | 0.527 |
SkinSen | 0.105 |
Carcinogencity | 0.149 |
EI | 0.007 |
Respiratory | 0.93 |
NR-Aromatase | 0.008 |
Antiviral | No |
Prediction | 0.678215 |